Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 25;57(2):2003002.
doi: 10.1183/13993003.03002-2020. Print 2021 Feb.

Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection

Frederik Trinkmann  1   2 , Michael Müller  1 , Alexandra Reif  1 , Nicolas Kahn  1 , Michael Kreuter  1 , Franziska Trudzinski  1 , Monika Eichinger  3 , Claus-Peter Heussel  3   4 , Felix J F Herth  5 ; Lung Network Rhine-Neckar-Region
Affiliations

Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection

Frederik Trinkmann et al. Eur Respir J. .

Abstract

About half of the patients recovering from SARS-CoV-2 have persistent symptoms and lower lung function as long as 2 months after infection. This is common even in younger SARS-CoV-2 convalescents with few comorbidities. https://bit.ly/38dyCYB

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: F. Trinkmann received travel support from Actelion, Berlin Chemie, Boehringer Ingelheim, Chiesi, Novartis, Mundipharma and TEVA as well as speaker or consultation fees from AstraZeneca, Berlin Chemie, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, GlaxoSmithKline, Novartis, Roche and Sanofi-Aventis, all outside the submitted work. Conflict of interest: M. Müller has nothing to disclose. Conflict of interest: A. Reif has nothing to disclose. Conflict of interest: N. Kahn received travel support from GSK and Berlin Chemie as well as speaker or consultation fees from Berlin Chemie and Roche, all outside the submitted work. Conflict of interest: M. Kreuter has nothing to disclose. Conflict of interest: F. Trudzinski received travel support from Actelion, Berlin Chemie, Chiesi, Novartis, and speaker or consultation fees from Novartis and Berlin Chemie, all outside the submitted work. Conflict of interest: M. Eichinger reports consultation fees from Roche, outside the submitted work. Conflict of interest: C-P. Heussel reports speaker or consultation fees from AstraZeneca, Basilea, Bayer, Bracco, Boehringer Ingelheim, Chiesi, Covidien, Essex, Gilead, Grifols, Intermune, Lilly, MEDA Pharma, MSD, Novartis, Roche, Schering-Plough, Siemens, Pfizer and Pierre Fabre, all outside the submitted work. Conflict of interest: F.J.F Herth has nothing to disclose.

References

    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239–1242. doi:10.1001/jama.2020.2648 - DOI - PubMed
    1. Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med 2020; 173: 362–367. doi:10.7326/M20-3012 - DOI - PMC - PubMed
    1. Zhang JJ, Dong X, Cao YY, et al. . Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020; 75: 1730–1741. doi:10.1111/all.14238 - DOI - PubMed
    1. Cooper BG, Stocks J, Hall GL, et al. . The Global Lung Function Initiative (GLI) Network: bringing the world's respiratory reference values together. Breathe (Sheff) 2017; 13: e56–e64. doi:10.1183/20734735.012717 - DOI - PMC - PubMed
    1. Quanjer PH, Tammeling GJ, Cotes JE, et al. . Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 6: Suppl. 16, 5–40. doi:10.1183/09041950.005s1693 - DOI - PubMed

MeSH terms